SBU vs. BIS
SBU (Leverage Shares 2X Long SBUX Daily ETF) and BIS (ProShares UltraShort Nasdaq Biotechnology) are both Leveraged Equities funds. SBU is actively managed, while BIS is passively managed. At a correlation of -0.26, they often move in opposite directions. SBU charges 0.75%/yr vs 0.95%/yr for BIS.
Performance
SBU vs. BIS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SBU achieves a 21.72% return, which is significantly higher than BIS's -10.87% return.
SBU
- 1D
- 0.85%
- 1M
- -16.51%
- YTD
- 21.72%
- 6M
- 11.90%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BIS
- 1D
- -4.83%
- 1M
- -2.10%
- YTD
- -10.87%
- 6M
- -8.91%
- 1Y
- -52.09%
- 3Y*
- -22.48%
- 5Y*
- -15.34%
- 10Y*
- -23.48%
SBU vs. BIS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
SBU Leverage Shares 2X Long SBUX Daily ETF | 21.72% | -0.84% |
BIS ProShares UltraShort Nasdaq Biotechnology | -10.87% | -4.80% |
Correlation
The correlation between SBU and BIS is -0.26, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 18, 2025 | -0.26 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBU vs. BIS — Risk / Return Rank
SBU
BIS
SBU vs. BIS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Leverage Shares 2X Long SBUX Daily ETF (SBU) and ProShares UltraShort Nasdaq Biotechnology (BIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| SBU | BIS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | -1.31 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.35 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.51 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.71 | -0.68 | +1.38 |
Drawdowns
SBU vs. BIS - Drawdown Comparison
The maximum SBU drawdown since its inception was -28.10%, smaller than the maximum BIS drawdown of -99.87%. Use the drawdown chart below to compare losses from any high point for SBU and BIS.
Loading charts...
Drawdown Indicators
| SBU | BIS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -28.10% | -99.87% | +71.77% |
Max Drawdown (1Y)Largest decline over 1 year | — | -54.50% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -66.87% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -74.80% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -95.25% | — |
Current DrawdownCurrent decline from peak | -20.00% | -99.86% | +79.86% |
Average DrawdownAverage peak-to-trough decline | -6.56% | -90.03% | +83.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 39.73% | — |
Volatility
SBU vs. BIS - Volatility Comparison
Loading charts...
Volatility by Period
| SBU | BIS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 14.76% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 31.31% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 59.78% | 39.91% | +19.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.78% | 43.78% | +16.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 59.78% | 46.38% | +13.40% |
SBU vs. BIS - Expense Ratio Comparison
SBU has a 0.75% expense ratio, which is lower than BIS's 0.95% expense ratio.
Dividends
SBU vs. BIS - Dividend Comparison
SBU has not paid dividends to shareholders, while BIS's dividend yield for the trailing twelve months is around 5.17%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | 5.17% | 5.25% | 3.73% | 1.75% | 0.00% | 0.00% | 0.45% | 2.11% | 0.37% |
SBU Leverage Shares 2X Long SBUX Daily ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
SBU and BIS have a correlation of -0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SBU is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SBU is cheaper with a 0.75% expense ratio, compared with 0.95% for BIS.
BIS has the higher dividend yield at 5.17%, compared with 0.00% for SBU.
They also come from different issuers: Leverage Shares and ProShares. Their fees differ too: 0.75% for SBU and 0.95% for BIS.
Find the right allocation for SBU and BIS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer